Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RLAY compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
RLAY
Relay Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
RLAY
Relay Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
RLAY
with
AMGN
Uncorrelated: r 0.22 · 500D.
No shared co-movers.
RLAY, solid
AMGN, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
RLAY
Relay Therapeutics, Inc.
Change
16.95
▼
−6.00%
· post 16.95
Mkt cap
$3.8B
Revenue
$350,000
Q2 FY26
Revenue
—
AMGN
Amgen Inc
Change
461.49
▼
−3.55%
· post 460.22
Closed
Nov 5 '26
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Closed
Nov 5 '26
RLAY
Relay Therapeutics, Inc.
vs
AMGN
Amgen Inc
16.95
▼
−6.00%
post 16.95
Price
461.49
▼
−3.55%
post 460.22
$3.8B
Mkt cap
$249.0B
Q2 FY26
$350,000
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
RLAY
16.95
▼
−6.00%
vs
AMGN
461.49
▼
−3.55%
Closed
Nov 5 '26